PortfoliosLab logoPortfoliosLab logo
ONC vs. SHEL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ONC vs. SHEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BeOne Medicines Ltd (ONC) and Shell plc (SHEL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ONC achieves a 4.02% return, which is significantly lower than SHEL's 27.49% return. Over the past 10 years, ONC has outperformed SHEL with an annualized return of 28.51%, while SHEL has yielded a comparatively lower 10.72% annualized return.


ONC

1D
-1.88%
1M
6.17%
6M
-7.16%
YTD
4.02%
1Y
5.69%
3Y*
15.23%
5Y*
-0.04%
10Y*
28.51%
ALL TIME*
25.59%

SHEL

1D
1.62%
1M
17.89%
6M
21.62%
YTD
27.49%
1Y
32.66%
3Y*
19.34%
5Y*
23.15%
10Y*
10.72%
ALL TIME*
6.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$113.27M$116.64M$92.58M
$678.43M$587.70M$593.39M

ONC vs. SHEL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ONC
BeOne Medicines Ltd
4.02%64.48%2.41%-18.00%-18.82%4.85%55.88%18.18%43.53%221.87%
SHEL
Shell plc
27.49%22.16%-0.87%20.19%36.18%34.27%-41.08%6.38%-7.23%21.67%

Correlation

The correlation between ONC and SHEL is -0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.03

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.08

Correlation (10Y)
Provides a long-term view across more market conditions.

0.13

Correlation (All Time)
Calculated using the full available price history since Feb 3, 2016

0.13

The correlation between ONC and SHEL shifts across timeframes, from -0.03 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ONC:

$33.77B

SHEL:

$256.45B

EPS

ONC:

$4.48

SHEL:

$9.02

PE Ratio

ONC:

70.58

SHEL:

10.20

PS Ratio

ONC:

6.31

SHEL:

0.89

PB Ratio

ONC:

7.69

SHEL:

1.43

Total Revenue (TTM)

ONC:

$5.74B

SHEL:

$296.60B

Gross Profit (TTM)

ONC:

$5.07B

SHEL:

$50.77B

EBITDA (TTM)

ONC:

$954.09M

SHEL:

$67.91B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ONC vs. SHEL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ONC
ONC Risk / Return Rank: 4747
Overall Rank
ONC Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
ONC Sortino Ratio Rank: 4545
Sortino Ratio Rank
ONC Omega Ratio Rank: 4444
Omega Ratio Rank
ONC Calmar Ratio Rank: 4949
Calmar Ratio Rank
ONC Martin Ratio Rank: 4949
Martin Ratio Rank

SHEL
SHEL Risk / Return Rank: 8080
Overall Rank
SHEL Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
SHEL Sortino Ratio Rank: 8080
Sortino Ratio Rank
SHEL Omega Ratio Rank: 7979
Omega Ratio Rank
SHEL Calmar Ratio Rank: 7777
Calmar Ratio Rank
SHEL Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ONC vs. SHEL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BeOne Medicines Ltd (ONC) and Shell plc (SHEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ONCSHELDifference
Sharpe ratioReturn per unit of total volatility

-1.35

Sortino ratioReturn per unit of downside risk

-1.56

Omega ratioGain probability vs. loss probability

1.06

1.26

-0.20

Calmar ratioReturn relative to maximum drawdown

0.16

1.80

-1.64

Martin ratioReturn relative to average drawdown

0.31

5.52

-5.21

ONC vs. SHEL - Sharpe Ratio Comparison

The current ONC Sharpe Ratio is 0.13, which is lower than the SHEL Sharpe Ratio of 1.48. The chart below compares the historical Sharpe Ratios of ONC and SHEL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ONC vs. SHEL - Drawdown Comparison

The maximum ONC drawdown since its inception was -69.96%, roughly equal to the maximum SHEL drawdown of -71.57%. Use the drawdown chart below to compare losses from any high point for ONC and SHEL.


Loading charts...

Drawdown Indicators


ONCSHELDifference

Max Drawdown

Largest peak-to-trough decline

-69.96%

-71.57%

+1.61%

Max Drawdown (1Y)

Largest decline over 1 year

-31.05%

-17.98%

-13.07%

Max Drawdown (3Y)

Largest decline over 3 years

-39.36%

-18.47%

-20.89%

Max Drawdown (5Y)

Largest decline over 5 years

-69.96%

-25.04%

-44.92%

Max Drawdown (10Y)

Largest decline over 10 years

-69.96%

-71.57%

+1.61%

Current Drawdown

Current decline from peak

-21.61%

-1.42%

-20.19%

Average Drawdown

Average peak-to-trough decline

-29.57%

-16.69%

-12.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.83%

5.86%

+9.97%

Volatility

ONC vs. SHEL - Volatility Comparison

BeOne Medicines Ltd (ONC) has a higher volatility of 7.82% compared to Shell plc (SHEL) at 7.11%. This indicates that ONC's price experiences larger fluctuations and is considered to be riskier than SHEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ONCSHELDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.82%

7.11%

+0.71%

Volatility (6M)

Calculated over the trailing 6-month period

24.26%

18.17%

+6.09%

Volatility (1Y)

Calculated over the trailing 1-year period

39.59%

21.99%

+17.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.37%

25.01%

+30.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.55%

30.67%

+24.88%

Dividends

ONC vs. SHEL - Dividend Comparison

ONC has not paid dividends to shareholders, while SHEL's dividend yield for the trailing twelve months is around 3.22%.


PositionTTM20252024202320222021202020192018201720162015
ONC
BeOne Medicines Ltd
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SHEL
Shell plc
3.22%3.90%4.39%3.76%3.48%3.78%5.69%6.27%6.27%2.75%6.49%8.17%

Financials

ONC vs. SHEL - Financials Comparison

This section allows you to compare key financial metrics between BeOne Medicines Ltd and Shell plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

ONC vs. SHEL - Profitability Comparison

The chart below illustrates the profitability comparison between BeOne Medicines Ltd and Shell plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

ONC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, BeOne Medicines Ltd reported a gross profit of 1.35B and revenue of 1.51B. Therefore, the gross margin over that period was 89.0%.

SHEL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Shell plc reported a gross profit of 18.48B and revenue of 94.66B. Therefore, the gross margin over that period was 19.5%.

ONC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, BeOne Medicines Ltd reported an operating income of 249.90M and revenue of 1.51B, resulting in an operating margin of 16.5%.

SHEL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Shell plc reported an operating income of 15.18B and revenue of 94.66B, resulting in an operating margin of 16.0%.

ONC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, BeOne Medicines Ltd reported a net income of 227.36M and revenue of 1.51B, resulting in a net margin of 15.0%.

SHEL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Shell plc reported a net income of 10.82B and revenue of 94.66B, resulting in a net margin of 11.4%.


Frequently Asked Questions


ONC and SHEL have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ONC has higher volatility (7.82%) compared to SHEL (7.11%). In terms of maximum drawdown, ONC dropped -69.96% vs SHEL's -71.57%.

SHEL currently has the higher Sharpe Ratio (1.48 vs 0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ONC and SHEL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer